Education
About Us
Working with TipRanks
Follow Us
PAWZ - ETF AI Analysis
Top Page
ProShares Pet Care ETF (PAWZ)
Rating:67Neutral
Price Target:―
Positive Factors
Solid Year-to-Date Performance
The ETF has delivered positive returns so far this year, showing that its pet care theme has been working for investors recently.
Strong Contribution from Key Holdings
Several of the largest positions, such as Freshpet, Idexx Laboratories, Virbac, Pet Valu, Merck, and CVS Group, have shown strong gains, helping support the fund’s overall performance.
Global Diversification Within Pet Care
Holdings spread across the U.S., UK, Europe, Canada, Japan, and Switzerland help reduce the risk of being tied to the economic conditions of just one country.
Negative Factors
High Concentration in Top Stocks
A small group of companies makes up a large share of the portfolio, which increases the impact if any of these individual stocks perform poorly.
Mixed Performance Among Major Holdings
Some important positions like Chewy, Zoetis, Pets at Home, and Nestlé have shown weak or lagging returns, which can drag on the ETF’s overall results.
Sector Concentration in Health Care and Consumer Stocks
Heavy exposure to health care and consumer-related sectors means the fund may be more sensitive to changes in spending on pet products and veterinary services.
PAWZ vs. SPDR S&P 500 ETF (SPY)
AUM45.26M
RegionGlobal
Expense Ratio0.50%
Beta0.69
IssuerProShares
Inception DateNov 05, 2018
Dividend Yield0.78%
Asset ClassEquity
Index TrackedFactSet Pet Care Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume5,605
30 Day Avg. Volume5,901
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
68.09Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering25
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PAWZ Summary
The ProShares Pet Care ETF (PAWZ) follows the FactSet Pet Care Index and focuses on companies that make money from pets and pet owners. It holds businesses involved in pet food, vet care, pet medicine, and pet retail, including well-known names like Chewy and Nestlé. Someone might invest in PAWZ to tap into the long-term growth of the global pet industry and to spread their money across many pet-related companies instead of picking just one stock. A key risk is that it is concentrated in the pet care sector, so it can rise or fall more than the overall market if this niche struggles.
How much will it cost me?The ProShares Pet Care ETF (PAWZ) has an expense ratio of 0.50%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed and focuses on a niche sector, which typically requires more specialized research and management.
What would affect this ETF?The ProShares Pet Care ETF could benefit from rising global pet ownership and increased spending on pet health and wellness, as pets are increasingly treated as family members. However, economic downturns or higher interest rates could negatively impact consumer spending on non-essential pet products and services, and regulatory changes in the healthcare sector might affect key holdings like Idexx Laboratories and Zoetis. The ETF’s global exposure also makes it sensitive to international market conditions and currency fluctuations.
PAWZ Top 10 Holdings
PAWZ is very much a “pets as family” play, with performance hinging on a handful of big names. Freshpet and Zoetis have been rising, giving the fund a healthy boost from the pet food and animal health side, while global staples giant Nestlé and Merck add steady, defensive muscle. On the flip side, Chewy and Trupanion have been lagging, acting like a leash on returns as investors shy away from high-growth, high-expectation stories. The fund is globally diversified but thematically concentrated in pet care, spanning health care and consumer names tied to pet spending.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Freshpet | 11.51% | $5.24M | $3.97B | -24.12% | 66 Neutral | |
| Chewy | 10.67% | $4.87M | $10.57B | -26.13% | 54 Neutral | |
| Idexx Laboratories | 10.07% | $4.59M | $51.69B | 49.81% | 78 Outperform | |
| Zoetis | 9.82% | $4.48M | $54.31B | -21.35% | 74 Outperform | |
| Virbac SA | 7.25% | $3.31M | €3.09B | 19.90% | 75 Outperform | |
| Nestlé SA | 4.46% | $2.03M | CHF209.77B | 11.07% | 71 Outperform | |
| Pet Valu Holdings Ltd. | 4.45% | $2.03M | C$2.01B | 23.80% | 65 Neutral | |
| Merck & Company | 4.24% | $1.93M | $307.60B | 31.71% | 80 Outperform | |
| Trupanion | 4.20% | $1.92M | $1.12B | -18.90% | 69 Neutral | |
| Oil-Dri Of America | 4.15% | $1.89M | $878.01M | 54.18% | 68 Neutral |
PAWZ Technical Analysis
Positive
―
Price Trends
55.47
Positive
55.09
Positive
56.13
Positive
Market Momentum
0.31
Negative
62.35
Neutral
97.70
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PAWZ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 55.64, equal to the 50-day MA of 55.47, and equal to the 200-day MA of 56.13, indicating a bullish trend. The MACD of 0.31 indicates Negative momentum. The RSI at 62.35 is Neutral, neither overbought nor oversold. The STOCH value of 97.70 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PAWZ.
PAWZ Peer Comparison
Comparison Results
Performance Comparison
PAWZ
ProShares Pet Care ETF
56.98
4.46
8.49%
FDCF
Fidelity Disruptive Communications ETF
―
―
―
EVX
VanEck Environmental Services ETF
―
―
―
FFND
Future Fund Active ETF
―
―
―
LOGO
Tidal Trust III Alpha Brands Consumption Leaders ETF
―
―
―
OND
ProShares On-Demand ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents